Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc.
26051 Merit Circle
Suite 102
Laguna Hills, CA 92653
United States
949-348-1188
https://adagiomedical.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 87
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Olav B. Bergheim | President, CEO, Secretary & Executive Director | 88.74k | N/A | 1950 |
| Mr. John T. Dahldorf | Chief Financial Officer | 405.34k | N/A | 1957 |
| Mr. Hakon Bergheim | Chief Operating Officer | 398.12k | N/A | N/A |
| Dr. Alex Babkin Ph.D. | Chief Technical Officer | N/A | N/A | N/A |
| Mr. Nabil Jubran | Chief Compliance Officer | N/A | N/A | N/A |
| Ilya Grigorov | Vice President of Global Marketing & Product Management | N/A | N/A | N/A |
| Tim Glynn | Vice President of Global Sales | N/A | N/A | N/A |
Description
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company was founded in 2011 and is headquartered in Laguna Hills, California.
Corporate Governance
Adagio Medical Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
